CinCor Pharma, Inc. Proceeds from Stock Options Exercised
CinCor Pharma, Inc. reported Proceeds from Stock Options Exercised of $400.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-11-03
- CinCor Pharma, Inc. proceeds from stock options exercised for the quarter ending 2022-09-30 was $400.00K.
- CinCor Pharma, Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $171.21K.
- CinCor Pharma, Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00.
- CinCor Pharma, Inc. proceeds from stock options exercised for fiscal 2021 was $1.40M.
- CinCor Pharma, Inc. proceeds from stock options exercised for fiscal 2020 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-03 | $400.00K 10-Q · filed 2022-11-03 | ||
| 2021-12-31 | $171.21K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $171.21K derived: sum of 2 quarters · filed 2022-11-03 | $1.40M 10-K · filed 2022-03-22 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.23M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $1.23M 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-22 |